WIL
VRTX icon

Winifred I. Li’s Vertex Pharmaceuticals VRTX Stock Holding History

Winifred I. Li’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$114K Buy
959
+45
+5% +$5.07K 0.11% 173
2014
Q3 		$103K Buy
914
+14
+2% +$1.33K 0.1% 184
2014
Q2 		$85K Hold
900
– – 0.07% 226
2014
Q1 		$64K Hold
900
– – 0.06% 255
2013
Q4 		$67K Hold
900
– – 0.06% 246
2013
Q3 		$68K Hold
900
– – 0.06% 236
2013
Q2 		$72K Buy
+900
New +$66.3K 0.07% 223

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Winifred I. Li's VRTX Position: Q4 2014 in Review

Winifred I. Li increased its Vertex Pharmaceuticals (VRTX) stake by 4.9% in Q4 2014, buying an estimated $5.07K and bringing the position to 959 shares worth $114K. The position accounts for 0.11% of the portfolio, ranked #173.

Winifred I. Li first reported a position in VRTX in Q2 2013 and has held it in 7 quarters since. 475 funds tracked by Wall St. Rank hold VRTX as of Q4 2014.

  • Winifred I. Li held 959 shares of Vertex Pharmaceuticals worth $114K as of Q4 2014.
  • Winifred I. Li bought 45 Vertex Pharmaceuticals shares in Q4 2014, an estimated $5.07K.
  • Vertex Pharmaceuticals made up 0.11% of Winifred I. Li's portfolio in Q4 2014, its #173 holding.
  • Winifred I. Li first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • 475 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2014.

Based on Winifred I. Li's 13F filing for Q4 2014, filed 19 Feb 2015.